Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Product (Disposables (Hemofilters & Bloodlines), Systems, & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), and Region (North America, Asia-Pacific, Europe) - Global Forecast to 2022

Report Code: MD 3842 Jul, 2017, by marketsandmarkets.com

[186 Pages Report] The global CRRT market is projected to reach USD 1,532.3 million by 2022 from USD 1,092.5 million in 2017, at a CAGR of 7.0% from 2017 to 2022.

Continuous Renal Replacement Therapy Market Dynamics

By product, the dialysates and replacement fluids segment is expected account for the largest share

Based on product, the global CRRT market is segmented into systems, dialysates & replacement fluids, and disposables (further sub-segmented into hemo-filters, tubing sets, and other disposables). In 2017, the dialysates and replacement fluids segment is expected to account for the largest share of the market owing to factors such as huge volume requirement of these products during CRRT procedures, as well as technological innovations.

By modality, the continuous veno-venous hemofiltration segment is expected account for the largest share

Based on modality, the global CRRT market is divided into continuous veno-venous hemofiltration (CVVH), continuous veno-venous hemodiafiltration (CVVHDF), continuous veno-venous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). The continuous veno-venous hemofiltration segment is expected to account for the largest share of the market in 2017. The large share of this segment can be attributed to factors such as high adoption rate of this modality among healthcare providers owing to its wide range of advantages over other CRRT modalities.

Europe is expected to account for the largest share of the CRRT market during the forecast period

The report covers the CRRT market across four key geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is expected to dominate the CRRT market in 2017. Increasing incidence of AKI due to rapidly aging population, high utilization rate of CRRT, and increasing number of approvals for CRRT systems across multiple applications are poised to drive the demand of CRRT products in the region. The Asia Pacific region is expected to grow at the highest CAGR due to large AKI and ESRD patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across countries in the region.

Continuous Renal Replacement Therapy Market Dynamics

Continuous Renal Replacement Therapy Market Dynamics

Market Dynamics

Growth in the CRRT market can be attributed to factors such as associated clinical advantages (such as better hemodynamic tolerability and efficient solute clearance) over intermittent blood purification techniques, increasing number of AKI patients, technological advancements & new product launches, and rising incidence of sepsis are also expected to further aid the market growth.

Driver - Increasing global incidence of AKI

Nephrologists/intensivists prefer CRRT for the treatment of AKI patients in ICUs; CRRT is considered as the gold standard for the treatment of hemodynamically unstable AKI patients as it provides better hemodynamic stability and improved efficiency of solute removal as compared to other dialysis techniques.

The growing worldwide incidence of AKI/AKF is therefore, expected to increase the demand for CRRT. The number of global AKI cases is expected to reach 1.7 million by 2020 from 800,000 cases in 2010, marking a CAGR of ~8% (Source: Baxter, 2015 Investor Conference). In the U.S. alone, an estimated 200,000 cases of acute kidney failure are registered each year (Source: NxStage Annual Report, 2013). Every year, approximately 50 million patients are admitted to ICUs in U.S. hospitals; nearly 50% of these patients develop AKI (Source: Society of Critical Care Medicine). Similarly, approximately 20% of hospitalized patients in the European Union (EU) reportedly develop AKI with a high rate of mortality (Source: International Society of Nephrology). In the U.K., approximately 13% to 18% of hospitalized patients develop AKI (Source: National Health Service, U.K.).

With age, the risk of developing AKI also increases. In 2011, the incidence rate of AKI among Medicare patients aged between 66 and 69 years was 14.9 cases per 1,000 patients, which increased to 18.8 cases per 1,000 patients aged between 70–74 years, 26.4 cases per 1,000 patients aged between 75–79 years, 35.9 cases per 1,000 patients aged between 80–84 years, and 49.6 cases per 1,000 patients aged 85 years and older (Source: USRDS). Additionally, factors such as decrease in blood volumes (as aging causes a reduction in total body water due to which there is less fluid in the bloodstream, resulting in a decrease in blood volume); previous medical complications such as heart abnormalities, weight issues, and issues related to diabetes and liver disease management; and increased intake of medicines can further exacerbate age-related renal changes.

With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to drive the growth of the CRRT market.

Restraint - High procedural cost of CRRT

The average cost for performing CRRT is USD 4,046, as compared to USD ~1,423 for performing Rationale for Intermittent Renal Replacement Therapy (IRRT) (Source: A Study Published by Nephrology Dialysis Transplantation, 2015). Nephrologists, especially in the emerging economies, are less inclined towards CRRT in comparison to IHD because of its high cost. The various factors contributing to the high cost of CRRT as compared to other blood perfusion techniques are listed below:

  • High nursing and technician cost for performing CRRT in ICU settings
  • Higher cost of filter sets and dialysates used in CRRT as compared to other modalities
  • For performing CRRT in ICUs, the nurse to patient ratio is 1:1, as compared to 1:2 for other treatments. Thus, the requirement for extra nurses further adds to the operation cost of CRRT

Scope of the Report

Report Metric

Details

Market Size Available for Years

2015–2022

Base Year Considered

2016

Forecast Period

2017–2022

Forecast Units

Value (USD)

Segments Covered

Product, Modality, Therapy, End User, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, Spain, Italy and RoE), APAC (China, Japan, India, South Korea, Australia and RoAPAC), and Latin America (Brazil, Mexico, Rest of LATAM), and Middle East & Africa

Companies Covered

Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGAA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun (Germany), Nxstage Medical, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Bellco S.R.L. (Italy), Infomed SA (Switzerland),, among others. Major 15 players covered.

This report categorizes the global continuous renal replacement therapy market into the following segments and subsegments:

Global Continuous Renal Replacement Therapy market, by Product

  • Dialysates and replacement fluids
  • Systems
  • Disposables
    • Hemo-filters
    • Blood sets (tubing sets)
    • Other disposables

Global Continuous Renal Replacement Therapy market, by Modality

  • Continuous veno-venous hemofiltration (CVVH)
  • Continuous veno-venous hemodiafiltration (CVVHDF)
  • Continuous veno-venous hemodialysis (CVVHD)
  • Slow continuous ultrafiltration (SCUF)

Global Continuous Renal Replacement Therapy market, by Therapy

  • Renal care
  • Non-renal care

Global Continuous Renal Replacement Therapy market, by End User

  • Hospitals
  • Dialysis centers

Global Continuous Renal Replacement Therapy market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Key Market Players

In 2016, the prominent players in the global CRRT market include Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGAA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun (Germany), Nxstage Medical, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Bellco S.R.L. (Italy), Infomed SA (Switzerland),, among others.

Baxter International held the leading position in the global CRRT market. The company has a strong foothold in the global CRRT market. The company’s key strengths are its significant geographic presence, a broad range of CRRT product offerings, solid R&D capabilities, and strong sales & distribution networks across the major markets. The company focuses mainly on organic growth strategy (such as new product development and launches) to sustain its leading position in the global CRRT market. The company is focusing on expanding its CRRT products offering through acquisitions. For instance, Baxter acquired Sweden-based Gambro AB (which offers products for CRRT) in September 2013.

Recent Developments

  • In 2017, Baxter signed an agreement with Satellite Healthcare (US) to distribute its dialysis products in the region
  • In 2016, Fresenius Medical Care opened a new research and production site in Schweinfurt for the development and production of dialysis equipment
  • In 2014, NIKKISO CO. acquired Baxter’s legacy CRRT business (which includes renal therapy products—the Aquarius System, Aqualine and Aquaset tubing sets, Aquamax hemofilters, and Accusol solutions)

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of Continuous Renal Replacement Therapy market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of Continuous Renal Replacement Therapy Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the new trends and advancements in the Continuous Renal Replacement Therapy market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 CRRT MARKET SEGMENTATION
           1.3.2 CRRT MARKET: GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY
    2.1 RESEARCH APPROACH
    2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY RESEARCH
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
    2.3 MARKET SIZE ESTIMATION METHODOLOGY
    2.4 MARKET DATA VALIDATION AND TRIANGULATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
    4.1 CRRT: MARKET OVERVIEW (2017)
    4.2 GLOBAL CRRT MARKET, BY PRODUCT, 2017 VS. 2022
    4.3 CRRT MARKET, BY MODALITY AND REGION (2017)
    4.4 GEOGRAPHIC SNAPSHOT: CRRT MARKET (2017)

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing global incidence of AKI
                    5.2.1.2 Growing number of ICU patients
                    5.2.1.3 Clinical advantages of CRRT over intermittent blood purification techniques
                    5.2.1.4 Technological advancements and new product launches
                    5.2.1.5 Increasing incidence of sepsis
                    5.2.1.6 Growing prevalence of diabetes and hypertension
           5.2.2 RESTRAINTS
                    5.2.2.1 High procedural cost of CRRT
                    5.2.2.2 Stringent regulatory guidelines for CRRT in North America
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Increasing applications of CRRT
                               5.2.3.2.1 Evolution of CRRT from a simple renal replacement treatment to a multi-organ support therapy (MOST)
                               5.2.3.2.2 Progression of CRRT from adaptive renal devices to multipurpose treatment machines
                    5.2.3.3 Ongoing research to establish safety and efficacy profile of CRRT
                    5.2.3.4 Development of CRRT system for pediatric patients
                               5.2.3.4.1 The CARPEDIEM project
                    5.2.3.5 Untapped growth opportunities in North American market
           5.2.4 CHALLENGES
                    5.2.4.1 High complexity of CRRT therapy
                               5.2.4.1.1 Lack of standard treatment guidelines in developing countries
                               5.2.4.1.2 Complications associated with CRRT
                    5.2.4.2 Shortage of trained ICU nurses in developed countries
                    5.2.4.3 Poor reimbursement scenario in developing countries
                    5.2.4.4 Lack of awareness about benefits of CRRT

6 INDUSTRY INSIGHTS
    6.1 INTRODUCTION
    6.2 REIMBURSEMENT SCENARIO
           6.2.1 NORTH AMERICA
           6.2.2 EUROPE
           6.2.3 ASIA PACIFIC (EXCLUDING JAPAN)
           6.2.4 JAPAN
           6.2.5 REST OF THE WORLD (ROW)
    6.3 REGULATORY LANDSCAPE
           6.3.1 NORTH AMERICA
           6.3.2 EUROPE
           6.3.3 ASIA PACIFIC
           6.3.4 REST OF THE WORLD (ROW)
           6.3.5 INDUSTRY TRENDS
                    6.3.5.1 Training programs for operation of CRRT devices
                    6.3.5.2 Rising adoption of user-friendly CRRT machines
                    6.3.5.3 Development of a CRRT system for pediatric patients
    6.4 PORTER’S FIVE FORCES ANALYSIS
           6.4.1 COMPETITIVE INTENSITY
           6.4.2 BARGAINING POWER OF BUYERS
           6.4.3 BARGAINING POWER OF SUPPLIERS
           6.4.4 THREAT OF SUBSTITUTES
           6.4.5 THREAT OF NEW ENTRANTS
    6.5 PRICING AND COST ANALYSIS
    6.6 STRATEGIC RECOMMENDATIONS
           6.6.1 DESIGN RECOMMENDATIONS
           6.6.2 KEY STRATEGIES FOR PLAYERS SEEKING TO ENTER CRRT MARKET

7 ADOPTION OF CRRT, BY REGION
    7.1 INTRODUCTION
    7.2 UTILIZATION OF CRRT PROCEDURES, BY REGION
    7.3 NUMBER OF CRRT PATIENTS, BY REGION

8 CRRT MARKET, BY PRODUCT
    8.1 INTRODUCTION
           8.1.1 DIALYSATES AND REPLACEMENT FLUIDS
           8.1.2 DISPOSABLES
                    8.1.2.1 Hemofilters
                    8.1.2.2 Bloodline sets (tubing sets)
                    8.1.2.3 Other disposables
           8.1.3 SYSTEMS

9 CRRT MARKET, BY MODALITY
    9.1 INTRODUCTION
    9.2 CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH)
    9.3 CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF)
    9.4 CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD)
    9.5 SLOW CONTINUOUS ULTRAFILTRATION (SCUF)

10 CRRT MARKET, BY THERAPY 
     10.1 RENAL CARE 
     10.2 NON-RENAL CARE 

11 CRRT MARKET, BY END USER
     11.1 HOSPITALS 
     11.2 DIALYSIS CENTERS 

12 CRRT MARKET, BY REGION
     12.1 INTRODUCTION
     12.2 EUROPE
             12.2.1 GERMANY
             12.2.2 U.K.
             12.2.3 FRANCE .
             12.2.4 ITALY .
             12.2.5 SPAIN
             12.2.6 REST OF EUROPE (ROE)
     12.3 NORTH AMERICA
             12.3.1 U.S.
             12.3.2 CANADA
     12.4 ASIA PACIFIC
             12.4.1 JAPAN
             12.4.2 CHINA
             12.4.3 INDIA
             12.4.4 SOUTH KOREA .
             12.4.5 AUSTRALIA
             12.4.6 REST OF ASIA PACIFIC (ROAPAC)
     12.5 LATIN AMERICA
             12.5.1 BRAZIL
             12.5.2 MEXICO
             12.5.3 REST OF LATIN AMERICA (ROLATAM)
     12.6 MIDDLE EAST AND AFRICA 

13 COMPETITIVE LANDSCAPE
     13.1 INTRODUCTION
             13.1.1 VISIONARY LEADERS
             13.1.2 INNOVATORS
             13.1.3 DYNAMIC DIFFERENTIATORS
             13.1.4 EMERGING COMPANIES
     13.2 STRENGTH OF PRODUCT PORTFOLIO
     13.3 BUSINESS STRATEGY EXCELLENCE
     13.4 COMPETITIVE INTENSITY
             13.4.1 EVALUATION PARAMETERS AND SCORES
             13.4.2 SCORING METHODOLOGY
             13.4.3 COMPETITIVE INTENSITY SCORE, BY COMPANY
                        13.4.3.1 Baxter International Inc.
                        13.4.3.2 Fresenius Medical Care AG & Co. KGaA
                        13.4.3.3 Nikkiso Co., Ltd.
                        13.4.3.4 B. Braun Melsungen AG
                        13.4.3.5 NxStage Medical, Inc.
             13.4.4 COMPETITIVE INTENSITY – MAPPING OF BAXTER INTERNATIONAL INC., FRESENIUS MEDICAL CARE AG & CO. KGAA, NIKKISO CO., LTD., B. BRAUN MELSUNGEN AG, AND NXSTAGE MEDICAL, INC.

*Top 25 companies analyzed for this studies are - Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc. (U.S.), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Bellco S.r.l. (Italy), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma spol. s.r.o. (Czech Republic), Medtronic plc (Ireland), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd (China), CytoSorbents Corporation (U.S.), BIOMEDICA spol. s r.o. (Czech Republic), Anjue Medical Equipment Co., Ltd. (China), Jiangxi Sanxin Medtec Co., Ltd. (China), Proxima Medicare (India), Nipro Corporation (Japan), CytoPherx, Inc. (U.S.), Dialysis Solutions Inc. (U.S.), Kimal Electronics Ltd (U.K.), BL Lifesciences (India)

14 COMPANY PROFILES
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     14.1 BAXTER INTERNATIONAL INC.
     14.2 FRESENIUS MEDICAL CARE AG & CO. KGAA
     14.3 NIKKISO CO., LTD.
     14.4 NXSTAGE MEDICAL, INC.
     14.5 B. BRAUN MELSUNGEN AG
     14.6 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
     14.7 BELLCO S.R.L. (A PART OF MEDTRONIC PLC)
     14.8 TORAY MEDICAL CO., LTD.
     14.9 INFOMED SA
     14.10 MEDICA S.P.A.
     14.11 MEDICAL COMPONENTS, INC.
     14.12 MEDITES PHARMA SPOL. S.R.O.
     14.13 MEDTRONIC PLC
     14.14 SWS HEMODIALYSIS CARE CO. LTD.
     14.15 NINGBO TIANYI MEDICAL APPLIANCE CO., LTD.

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

15 APPENDIX
     15.1 INSIGHTS OF INDUSTRY EXPERTS
     15.2 DISCUSSION GUIDE
     15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     15.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
     15.5 AVAILABLE CUSTOMIZATIONS
     15.6 RELATED REPORTS
     15.7 AUTHOR DETAILS


LIST OF TABLES (100 Tables)

TABLE 1 CRRT MACHINE ASP, BY MANUFACTURER, 2016 (USD)
TABLE 2 CRRT BLOODLINES AND DIALYSATE BAGS ASP, 2016 (USD)
TABLE 3 CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 4 CRRT DIALYSATES & REPLACEMENT FLUIDS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 5 EUROPE: CRRT DIALYSATES & REPLACEMENT FLUIDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 6 NORTH AMERICA: CRRT DIALYSATES & REPLACEMENT FLUIDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 7 ASIA-PACIFIC: CRRT DIALYSATES & REPLACEMENT FLUIDS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 8 CRRT DISPOSABLES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 9 CRRT DISPOSABLES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 10 EUROPE: CRRT DISPOSABLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 11 NORTH AMERICA: CRRT DISPOSABLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 12 ASIA-PACIFIC: CRRT DISPOSABLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 13 CRRT SYSTEMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 14 EUROPE: CRRT SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 15 NORTH AMERICA: CRRT SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 16 ASIA-PACIFIC: CRRT SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 17 CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 18 CRRT MARKET FOR CVVH, BY REGION, 2015–2022 (USD MILLION)
TABLE 19 EUROPE: CRRT MARKET FOR CVVH, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 20 NORTH AMERICA: CRRT MARKET FOR CVVH, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 21 ASIA-PACIFIC: CRRT MARKET FOR CVVH, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 22 CRRT MARKET FOR CVVHDF, BY REGION, 2015–2022 (USD MILLION)
TABLE 23 EUROPE: CRRT MARKET FOR CVVHDF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 24 NORTH AMERICA: CRRT MARKET FOR CVVHDF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 25 ASIA-PACIFIC: CRRT MARKET FOR CVVHDF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 26 CRRT MARKET FOR CVVHD, BY REGION, 2015–2022 (USD MILLION)
TABLE 27 EUROPE: CRRT MARKET FOR CVVHD, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 28 NORTH AMERICA: CRRT MARKET FOR CVVHD, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 29 ASIA-PACIFIC: CRRT MARKET FOR CVVHD, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 30 CRRT MARKET FOR SCUF, BY REGION, 2015–2022 (USD MILLION)
TABLE 31 EUROPE: CRRT MARKET FOR SCUF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 32 NORTH AMERICA: CRRT MARKET FOR SCUF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 33 ASIA-PACIFIC: CRRT MARKET FOR SCUF, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 34 CRRT MARKET, BY THERAPY, 2015–2022 (USD MILLION)
TABLE 35 CRRT MARKET FOR RENAL CARE, BY REGION, 2015–2022 (USD MILLION)
TABLE 36 EUROPE: CRRT MARKET FOR RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 37 NORTH AMERICA: CRRT MARKET FOR RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 38 ASIA-PACIFIC: CRRT MARKET FOR RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 39 CRRT MARKET FOR NON-RENAL CARE, BY REGION, 2015–2022 (USD MILLION)
TABLE 40 EUROPE: CRRT FOR NON-RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 41 NORTH AMERICA: CRRT FOR NON-RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 42 ASIA-PACIFIC: CRRT FOR NON-RENAL CARE, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 43 CRRT MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 44 CRRT MARKET FOR HOSPITALS, BY REGION, 2015–2022 (USD MILLION)
TABLE 45 EUROPE: CRRT MARKET FOR HOSPITALS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 46 NORTH AMERICA: CRRT MARKET FOR HOSPITALS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 47 ASIA-PACIFIC: CRRT MARKET FOR HOSPITALS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 48 CRRT MARKET FOR DIALYSIS CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 49 EUROPE: CRRT MARKET FOR DIALYSIS CENTERS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 50 NORTH AMERICA: CRRT MARKET FOR DIALYSIS CENTERS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 51 ASIA-PACIFIC: CRRT MARKET FOR DIALYSIS CENTERS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 52 CRRT MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 53 EUROPE: CRRT MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 54 EUROPE: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 55 EUROPE: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 56 GERMANY: CRRT MARKET, BY PRODUCT, 2013-2020 (USD MILLION)
TABLE 57 GERMANY: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 58 U.K.: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 59 U.K.: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 60 FRANCE: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 61 FRANCE: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 62 SPAIN: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 63 SPAIN: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 64 ITALY: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 65 ITALY: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 66 ROE: CRRT MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 ROE: CRRT MARKET SIZE, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 68 NORTH AMERICA: CRRT MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 69 NORTH AMERICA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 70 NORTH AMERICA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 71 U.S.: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 72 U.S.: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 73 CANADA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 74 CANADA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 75 ASIA PACIFIC: CRRT MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 76 ASIA PACIFIC: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 77 ASIA PACIFIC: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 78 JAPAN: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 79 JAPAN: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 80 CHINA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 81 CHINA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 82 INDIA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 83 INDIA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 84 SOUTH KOREA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 85 SOUTH KOREA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 86 AUSTRALIA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 87 AUSTRALIA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 88 ROAPAC: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 89 ROAPAC: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 90 LATIN AMERICA: CRRT MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 91 LATIN AMERICA: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 92 LATIN AMERICA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 93 BRAZIL: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 94 BRAZIL: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 95 MEXICO: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 96 MEXICO: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 97 ROLATAM: CRRT MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 98 ROLATAM: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)
TABLE 99 MIDDLE EAST AND AFRICA: CRRT MARKET, BY PRODUCT, 2015–2022 (USDMILLION)
TABLE 100 MIDDLE EAST AND AFRICA: CRRT MARKET, BY MODALITY, 2015–2022 (USD MILLION)


LIST OF FIGURES (52 Figures)

FIGURE 1 GLOBAL CRRT MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 CRRT MARKET: KEY INSIGHTS FROM SUPPLY-SIDE PARTICIPANTS
FIGURE 5 CRRT MARKET: KEY INSIGHTS FROM DEMAND–SIDE PARTICIPANTS
FIGURE 6 ESTIMATION OF CRRT PROCEDURAL VOLUME
FIGURE 7 RESEARCH METHODOLOGY: TOP-DOWN APPROACH [FOR MARKET SIZE ESTIMATION OF CRRT DISPOSABLES (BLOODLINE SETS, HEMOFILTERS, AND OTHER DISPOSABLES)
FIGURE 8 RESEARCH METHODOLOGY: TOP-DOWN APPROACH (FOR MARKET SIZE ESTIMATION OF CRRT SYSTEMS)
FIGURE 9 RESEARCH METHODOLOGY: BOTTOM-UP APPROACH (FOR ESTIMATION OF CRRT MARKET SIZE)
FIGURE 10 DATA TRIANGULATION STEPS (TOP-DOWN AND BOTTOM-UP APPROACHES)
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 GLOBAL CRRT MARKET BY PRODUCT, 2017-2022 (USD MILLION)
FIGURE 13 HEMOFILTERS SEGMENT TO HOLD LARGEST SHARE OF CRRT DISPOSABLES MARKET IN 2017 (USD MILLION)
FIGURE 14 CVVHDF TO BE THE FASTEST-GROWING CRRT MODALITY DURING FORECAST PERIOD
FIGURE 15 ASIA PACIFIC CRRT MARKET TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 16 RISING PREVALENCE OF AKI TO DRIVE GLOBAL CRRT MARKET DURING FORECAST PERIOD
FIGURE 17 DIALYSATES & REPLACEMENT FLUIDS TO DOMINATE GLOBAL CRRT PRODUCTS MARKET DURING FORECAST PERIOD
FIGURE 18 EUROPE TO DOMINATE GLOBAL CRRT MARKET ACROSS ALL MODALITIES IN 2017
FIGURE 19 EUROPE TO DOMINATE GLOBAL CRRT MARKET DURING FORECAST PERIOD
FIGURE 20 CRRT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 GLOBAL INCIDENCE OF AKI CASES, 2010 VS. 2015 VS. 2020
FIGURE 22 KEY NON-RENAL APPLICATIONS OF CRRT
FIGURE 23 CRRT-ASSOCIATED TECHNICAL AND CLINICAL COMPLICATIONS
FIGURE 24 KEY FACTORS AFFECTING REIMBURSEMENT RATES FOR CRRT PROCEDURES
FIGURE 25 GLOBAL CRRT REIMBURSEMENT SCENARIO (2016)
FIGURE 26 MEDICAL REIMBURSEMENT STRUCTURE IN EUROPE
FIGURE 27 GLOBAL REGULATORY BODIES FOR APPROVAL OF NEW CRRT PRODUCTS
FIGURE 28 PORTER’S FIVE FORCES ANALYSIS – GLOBAL CRRT MARKET
FIGURE 29 DESIGN RECOMMENDATIONS FOR CRRT MACHINES
FIGURE 30 UTILIZATION OF CRRT VS IHD AND SLEDD FOR TREATMENT OF RENAL PATIENTS IN ICUS, BY REGION (2016)
FIGURE 31 NUMBER OF CRRT PATIENTS ACROSS THE GLOBE, 2016
FIGURE 32 GLOBAL CRRT MARKET, BY PRODUCT (2017 VS. 2022)
FIGURE 33 CRRT BLOOD PURIFICATION MODALITIES
FIGURE 34 GLOBAL CRRT MARKET, BY MODALITY (2017 VS. 2022)
FIGURE 35 EUROPE TO DOMINATE GLOBAL CRRT MARKET DURING FORECAST PERIOD (USD MILLION)
FIGURE 36 EUROPE: CRRT MARKET SNAPSHOT
FIGURE 37 NORTH AMERICA: CRRT MARKET SNAPSHOT
FIGURE 38 ASIA PACIFIC: CRRT MARKET SNAPSHOT
FIGURE 39 ROW: CRRT MARKET SNAPSHOT
FIGURE 40 COMPETITIVE LEADERSHIP MAPPING
FIGURE 41 GLOBAL CRRT MARKET SHARE, BY KEY PLAYER (2016)
FIGURE 42 SCORING METHODOLOGY
FIGURE 43 COMPARISON OF COMPETITIVE INTENSITY SCORES
FIGURE 44 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND FOCUS ON CRRT
FIGURE 45 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2016)
FIGURE 46 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2016)
FIGURE 47 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2015)
FIGURE 48 NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT (2016)
FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
FIGURE 50 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2015)
FIGURE 51 TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT (2016)
FIGURE 52 MEDTRONIC PLC.: COMPANY SNAPSHOT (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
8 7 5 5 8  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Continuous Renal Replacement Therapy Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Continuous Renal Replacement Therapy Market

Request For Special Pricing
Report Code
MD 3842
Published ON
Jul, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Continuous Renal Replacement Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home